Tilray Brands Inc (TLRY)
2.40
+0.02
(+0.63%)
USD |
NASDAQ |
Sep 22, 16:00
2.38
-0.02
(-0.83%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 1.729B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -14.29% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.374 |
Price to Book Value | 0.5215 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.1749 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 95.16% |
Profile
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol. |
URL | https://www.tilray.com |
Investor Relations URL | https://ir.tilray.com/ |
HQ State/Province | Ontario |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Equity Style | Mid Cap/Value |
Next Earnings Release | Oct. 04, 2023 |
Last Earnings Release | Jul. 26, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol. |
URL | https://www.tilray.com |
Investor Relations URL | https://ir.tilray.com/ |
HQ State/Province | Ontario |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Equity Style | Mid Cap/Value |
Next Earnings Release | Oct. 04, 2023 |
Last Earnings Release | Jul. 26, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |